Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedAdded revision v3.4.2 to the history; removed the funding-lapse notice and revision v3.4.1.SummaryDifference0.4%

- Check57 days agoChange DetectedA site-wide funding notice was added and the page revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check64 days agoChange DetectedUpdates to the history page include a Show glossary option, green and red color-coding explanations for additions and deletions, and a new revision label (v3.4.0) replacing v3.3.4. These changes are cosmetic UI updates and do not modify the underlying trial records; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the Record History page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.